Literature DB >> 25604463

Anogenital giant seborrheic keratosis.

Uwe Wollina1, Anastasiya Chokoeva2, Georgi Tchernev3,4, Birgit Heinig5, Jacqueline Schönlebe6.   

Abstract

Seborrheic keratosis (SK) are very common benign epidermal tumors. Giant seborrheic keratosis (GSK) is a rare variant with clinical characteristics, which leads very often to misdiagnosis. A genital site of SK is very unusual clinical manifestation and although the cause is still unknown, current literature data point to a possible pathogenetic role of chronic friction and HPV infection. The rare genital localization makes Buschke-Löwenstein tumor and verrucous carcinoma important differential diagnoses. GSK may also show some clinical features of a melanoacanthoma, which makes cutaneous melanoma as another possible differential diagnosis. The clinical diagnosis of genital GSK is often a very difficult one, because the typical clinical features of GSK disappear and the most common dermoscopic features of GSK are usually not seen in the genital region lesions. The diagnosis of GSK of the anogenital area should be made only and always after the exact histological verification and variety of differential diagnosis should be carefully considered. The treatment of GSK is primary surgically. We present a rare case of GSK with concomitant HPV infection in the anogenital region of 72-year-old patient. Surgical approach was performed with excellent outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25604463     DOI: 10.23736/S0392-0488.16.04945-2

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  2 in total

Review 1.  Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options.

Authors:  Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2018-11-23

Review 2.  Recent advances in managing and understanding seborrheic keratosis.

Authors:  Uwe Wollina
Journal:  F1000Res       Date:  2019-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.